
TY  - JOUR
TI  - Poster - Gastroenterology
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 30
IS  - S4
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.13188
DO  - doi:10.1111/jgh.13188
SP  - 28
EP  - 159
PY  - 2015
ER  - 

TY  - JOUR
TI  - 4th Meeting of Middle European Societies for Immunology and Allergology, 28–30 November 2019, Samorin, Slovakia
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S4
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201970500
DO  - doi:10.1002/eji.201970500
SP  - 1
EP  - 75
PY  - 2019
ER  - 

TY  - JOUR
TI  - Sunday, December 6, 2009 Poster Session 2 8:00 a.m.-6:00 p.m.
JO  - Epilepsia
VL  - 50
IS  - s11
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2009.02377_3.x
DO  - doi:10.1111/j.1528-1167.2009.02377_3.x
SP  - 158
EP  - 308
PY  - 2009
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12701
DO  - doi:10.1111/tri.12701
SP  - 134
EP  - 276
PY  - 2015
ER  - 

TY  - JOUR
AU  - Grek, Christina L.
AU  - Rhett, J. Matthew
AU  - Ghatnekar, Gautam S.
TI  - Cardiac to cancer: Connecting connexins to clinical opportunity
JO  - FEBS Letters
VL  - 588
IS  - 8
SN  - 0014-5793
UR  - https://doi.org/10.1016/j.febslet.2014.02.047
DO  - doi:10.1016/j.febslet.2014.02.047
SP  - 1349
EP  - 1364
KW  - Connexin43
KW  - Gap junction
KW  - ACT1 peptide
KW  - Wound healing
KW  - CNS
KW  - Cancer
KW  - Therapeutic
KW  - Purinergic
PY  - 2014
AB  - Gap junctions and their connexin components are indispensable in mediating the cellular coordination required for tissue and organ homeostasis. The critical nature of their existence mandates a connection to disease while at the same time offering therapeutic potential. Therapeutic intervention may be offered through the pharmacological and molecular disruption of the pathways involved in connexin biosynthesis, gap junction assembly, stabilization, or degradation. Chemical inhibitors aimed at closing connexin channels, peptide mimetics corresponding to short connexin sequences, and gene therapy approaches have been incredibly useful molecular tools in deciphering the complexities associated with connexin biology. Recently, therapeutic potential in targeting connexins has evolved from basic research in cell-based models to clinical opportunity in the form of human trials. Clinical promise is particularly evident with regards to targeting connexin43 in the context of wound healing. The following review is aimed at highlighting novel advances where the pharmacological manipulation of connexin biology has proven beneficial in animals or humans.
ER  - 

TY  - JOUR
TI  - Abstracts - Oral and Poster Presentations from the XII International Congress of Dermatology April 18-22, 2017 - Buenos Aires, Argentina
JO  - International Journal of Dermatology
JA  - Int J Dermatol
VL  - 56
IS  - 11
SN  - 0011-9059
UR  - https://doi.org/10.1111/ijd.13720
DO  - doi:10.1111/ijd.13720
SP  - 1204
EP  - 1316
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 30
IS  - S1
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.26295
DO  - doi:10.1002/mds.26295
SP  - S1
EP  - S567
PY  - 2015
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12700
DO  - doi:10.1111/tri.12700
SP  - 1
EP  - 133
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
JA  - Immunology
VL  - 143
IS  - s2
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12406
DO  - doi:10.1111/imm.12406
SP  - 62
EP  - 176
PY  - 2014
ER  - 

TY  - JOUR
TI  - Monday, 25 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_1.x
DO  - doi:10.1111/j.1538-7836.2011.04380_1.x
SP  - 1
EP  - 250
PY  - 2011
ER  - 

TY  - JOUR
TI  - Environmental impacts on the genome and epigenome: Mechanisms and risks, October 15–19, 2011
JO  - Environmental and Molecular Mutagenesis
JA  - Environ. Mol. Mutagen.
VL  - 52
IS  - S1
SN  - 0893-6692
UR  - https://doi.org/10.1002/em.20693
DO  - doi:10.1002/em.20693
SP  - S1
EP  - S87
PY  - 2011
ER  - 

TY  - JOUR
TI  - MONDAY SESSION
JO  - Journal of Neurochemistry
VL  - 102
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.0022-3042.2007.04726.x
DO  - doi:10.1111/j.0022-3042.2007.04726.x
SP  - 1
EP  - 75
PY  - 2007
ER  - 

TY  - JOUR
AU  - Cui, Liang
AU  - Lu, Haitao
AU  - Lee, Yie Hou
TI  - Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 37
IS  - 6
SN  - 0277-7037
UR  - https://doi.org/10.1002/mas.21562
DO  - doi:10.1002/mas.21562
SP  - 772
EP  - 792
KW  - disease
KW  - liquid chromatography
KW  - mass spectrometry
KW  - medicine
KW  - metabolomics
KW  - untargeted metabolomics
PY  - 2018
AB  - In the past decade, advances in liquid chromatography-mass spectrometry (LC-MS) have revolutionized untargeted metabolomics analyses. By mining metabolomes more deeply, researchers are now primed to uncover key metabolites and their associations with diseases. The employment of untargeted metabolomics has led to new biomarker discoveries and a better mechanistic understanding of diseases with applications in precision medicine. However, many major pertinent challenges remain. First, compound identification has been poor, and left an overwhelming number of unidentified peaks. Second, partial, incomplete metabolomes persist due to factors such as limitations in mass spectrometry data acquisition speeds, wide-range of metabolites concentrations, and cellular/tissue/temporal-specific expression changes that confound our understanding of metabolite perturbations. Third, to contextualize metabolites in pathways and biology is difficult because many metabolites partake in multiple pathways, have yet to be described species specificity, or possess unannotated or more-complex functions that are not easily characterized through metabolomics analyses. From a translational perspective, information related to novel metabolite biomarkers, metabolic pathways, and drug targets might be sparser than they should be. Thankfully, significant progress has been made and novel solutions are emerging, achieved through sustained academic and industrial community efforts in terms of hardware, computational, and experimental approaches. Given the rapidly growing utility of metabolomics, this review will offer new perspectives, increase awareness of the major challenges in LC-MS metabolomics that will significantly benefit the metabolomics community and also the broader the biomedical community metabolomics aspire to serve.
ER  - 

TY  - JOUR
TI  - Poster Session 2, Monday 12 September
JO  - European Journal of Neurology
VL  - 18
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2011.03552.x
DO  - doi:10.1111/j.1468-1331.2011.03552.x
SP  - 344
EP  - 620
PY  - 2011
ER  - 

TY  - JOUR
TI  - 58th ANNUAL MEETING AND EXHIBITION
JO  - Medical Physics
JA  - Med. Phys.
VL  - 43
IS  - 6Part47
SN  - 0094-2405
UR  - https://doi.org/10.1002/j.2473-4209.2016.tb00353.x
DO  - doi:10.1002/j.2473-4209.2016.tb00353.x
SP  - 3212
EP  - 3938
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Maternal Medicine
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 123
IS  - S1
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.13987
DO  - doi:10.1111/1471-0528.13987
SP  - 13
EP  - 39
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Sessions: Basic
JO  - American Journal of Transplantation
VL  - 14
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12888
DO  - doi:10.1111/ajt.12888
SP  - 278
EP  - 419
PY  - 2014
ER  - 

TY  - JOUR
TI  - Winter Meeting 2012. 201st Scientific Meeting of the Pathological Society of Great Britain & Ireland, 5–6 January
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 226
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.4005
DO  - doi:10.1002/path.4005
SP  - S1
EP  - S34
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S2
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.12237
DO  - doi:10.1111/nep.12237
SP  - 77
EP  - 202
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 1: Gene Expression and Therapy; Health Care Delivery/Access/Quality
JO  - Hepatology
JA  - Hepatology
VL  - 62
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28213
DO  - doi:10.1002/hep.28213
SP  - 456A
EP  - 497A
PY  - 2015
ER  - 
